<p>隨着 2025 年接近尾聲，美國股市經歷了一個強勁的年度，主要指數均實現了顯著的漲幅，儘管最後略顯疲軟。在這種環境下，識別高內部持股的成長型公司尤為吸引人，因為內部人士的信心通常預示着長期成功的潛力以及與股東利益的一致性。</p>
<h3>美國高內部持股的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>超微電腦 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們高內部持股快速成長的美國公司篩選器中的 211 只股票的完整列表。</p>
<p>下面我們重點介紹幾家我們獨家的篩選器中的最愛。</p>
<h2>Abeona Therapeutics (ABEO)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Abeona Therapeutics Inc.是一家臨牀階段的生物製藥公司，專注於開發針對危及生命疾病的基因和細胞療法，市值為 2.8071 億美元。</p>
<p><strong>運營：</strong> Abeona Therapeutics Inc.目前沒有報告任何收入細分，因為它專注於開發針對危及生命疾病的基因和細胞療法。</p>
<p><strong>內部持股：</strong> 10.3%</p>
<p>Abeona Therapeutics 是一家擁有大量內部持股的公司，正經歷顯著的增長潛力。最近實現盈利，交易價格低於其估計的公允價值和同行。儘管過去一年股東稀釋了一些股份，但 Abeona 的收入預計將以每年 42.5% 的速度增長，超過美國市場的平均水平。該公司最近的產品開發包括 FDA 批准的 ZEVASKYN 基因療法，用於治療罕見皮膚疾病，以及戰略性領導任命，以增強業務運營和發展戰略。</p>
<ul>
<li>點擊這裏深入瞭解 Abeona Therapeutics 的完整分析和未來增長報告。</li>
<li>我們的估值報告揭示了 Abeona Therapeutics 的股票可能在折扣交易。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 ABEO 收益和收入增長</p>
<h2>Streamex (STEX)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Streamex Corp.是一家現實世界資產代幣化公司，提供機構級基礎設施，市值為 4.6152 億美元。</p>
<p><strong>運營：</strong> 提供的文本中未指定 Streamex Corp.的收入細分。</p>
<p><strong>內部持股：</strong> 16.1%</p>
<p>Streamex 擁有顯著的內部持股，通過創新舉措如開放項目和戰略合作伙伴關係，正處於增長的有利位置。該公司專注於代幣化現實世界資產，例如其黃金支持的 GLDY 代幣，與監管進展相一致，以增強市場透明度和效率。儘管在 2025 年第三季度遭遇了 1558 萬美元的財務損失和股東稀釋，Streamex 的收入預計將以每年超過 100% 的速度快速增長，超過美國市場的平均水平。</p>
<ul>
<li>點擊這裏訪問我們的完整增長分析報告，以瞭解 Streamex 的動態。</li>
<li>根據我們的估值報告，Streamex 的股價可能偏高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 STEX 收益和收入增長</p>
<h2>Fiverr International (FVRR)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Fiverr International Ltd.運營一個全球在線市場，市值約為 7.2795 億美元。</p>
<p><strong>運營：</strong> 該公司從其互聯網軟件和服務部門產生 4.2740 億美元的收入。</p>
<p><strong>內部持股：</strong> 11.6%</p>
<p>Fiverr International 擁有大量內部持股，展現出強勁的收益增長，在 2025 年第三季度報告的淨收入為 554 萬美元，而去年為 135 萬美元。儘管收入增長預測落後於更廣泛的市場，年增長率為 6.3%，但其收益預計將以每年 47.5% 的速度顯著增長，超過市場平均水平。目前交易價格低於公允價值估計，分析師的目標價格暗示在強勁利潤擴張預期下，股票有升值潛力。</p>
<ul>
<li>點擊這裏通過我們的詳細分析未來增長報告發現 Fiverr International 的細微差別。</li>
<li>根據我們的估值報告，Fiverr International 的股價可能偏低。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 FVRR 持股分佈</p>
<h2>接下來該怎麼辦？</h2>
<ul>
<li>解鎖更多寶藏！我們的高內部持股快速成長的美國公司篩選器為您挖掘了 208 家公司供您探索。點擊這裏揭示我們精心策劃的 211 家高內部持股快速成長的美國公司列表。</li>
<li>準備好不同的投資方式了嗎？通過提供可靠收入流的穩健分紅股來多樣化您的投資組合，以應對潛在的市場動盪。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
<p>國防和災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達服務，適用於任何地方。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>由 CiTech 贊助</p>

超微電腦

FVRR

Abeona治療

<p>隨着 2025 年接近尾聲，美國股市顯示出顯著的增長，激發了對高內部持股的成長型公司的興趣。值得注意的公司包括超微電腦（Super Micro Computer，SMCI）、StubHub Holdings（STUB）和 SES AI（SES），它們都展現了強勁的盈利增長。亮點包括 Abeona Therapeutics，該公司正在開發基因療法，預計收入增長為 42.5%；以及 Streamex Corp.，專注於將現實世界資產進行代幣化，預計收入增長超過 100%。Fiverr International 也顯示出潛力，預計盈利增長為 47.5%</p>

<p>As 2025 comes to a close, the U.S. stock market has experienced a robust year with significant gains across major indices despite ending on a slightly downbeat note. In this environment, identifying growth companies with high insider ownership can be particularly appealing as insider confidence often signals potential for long-term success and alignment of interests with shareholders.</p>
<div class="lb-trans"><p>隨着 2025 年接近尾聲，美國股市經歷了一個強勁的年度，主要指數均實現了顯著的漲幅，儘管最後略顯疲軟。在這種環境下，識別高內部持股的成長型公司尤為吸引人，因為內部人士的信心通常預示着長期成功的潛力以及與股東利益的一致性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美國高內部持股的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Super Micro Computer (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>超微電腦 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 211 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們高內部持股快速成長的美國公司篩選器中的 211 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>下面我們重點介紹幾家我們獨家的篩選器中的最愛。</p>
</div><h2>Abeona Therapeutics (ABEO)</h2>
<div class="lb-trans"><h2>Abeona Therapeutics (ABEO)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing gene and cell therapies for life-threatening diseases, with a market cap of $280.71 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Abeona Therapeutics Inc.是一家臨牀階段的生物製藥公司，專注於開發針對危及生命疾病的基因和細胞療法，市值為 2.8071 億美元。</p>
</div><p><strong>Operations:</strong> Abeona Therapeutics Inc. currently does not report any revenue segments as it is focused on developing gene and cell therapies for life-threatening diseases.</p>
<div class="lb-trans"><p><strong>運營：</strong> Abeona Therapeutics Inc.目前沒有報告任何收入細分，因為它專注於開發針對危及生命疾病的基因和細胞療法。</p>
</div><p><strong>Insider Ownership:</strong> 10.3%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 10.3%</p>
</div><p>Abeona Therapeutics, a company with substantial insider ownership, is experiencing significant growth potential. Recently becoming profitable, it trades at a value below its estimated fair value and peers. Despite some shareholder dilution over the past year, Abeona's revenue is forecast to grow at 42.5% annually, outpacing the US market average. The company's recent product developments include FDA-approved ZEVASKYN gene therapy for treating rare skin disorders and strategic leadership appointments to enhance business operations and development strategies.</p>
<div class="lb-trans"><p>Abeona Therapeutics 是一家擁有大量內部持股的公司，正經歷顯著的增長潛力。最近實現盈利，交易價格低於其估計的公允價值和同行。儘管過去一年股東稀釋了一些股份，但 Abeona 的收入預計將以每年 42.5% 的速度增長，超過美國市場的平均水平。該公司最近的產品開發包括 FDA 批准的 ZEVASKYN 基因療法，用於治療罕見皮膚疾病，以及戰略性領導任命，以增強業務運營和發展戰略。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Abeona Therapeutics.</li>
<li>Our valuation report unveils the possibility Abeona Therapeutics' shares may be trading at a discount.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏深入瞭解 Abeona Therapeutics 的完整分析和未來增長報告。</li>
<li>我們的估值報告揭示了 Abeona Therapeutics 的股票可能在折扣交易。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth"/></p>
<p>ABEO Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 ABEO 收益和收入增長</p>
</div><h2>Streamex (STEX)</h2>
<div class="lb-trans"><h2>Streamex (STEX)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Streamex Corp. is a real world asset tokenization company that provides institutional-grade infrastructure, with a market cap of $461.52 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Streamex Corp.是一家現實世界資產代幣化公司，提供機構級基礎設施，市值為 4.6152 億美元。</p>
</div><p><strong>Operations:</strong> Streamex Corp.'s revenue segments are not specified in the provided text.</p>
<div class="lb-trans"><p><strong>運營：</strong> 提供的文本中未指定 Streamex Corp.的收入細分。</p>
</div><p><strong>Insider Ownership:</strong> 16.1%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 16.1%</p>
</div><p>Streamex, with significant insider ownership, is positioned for growth through innovative initiatives like Project Open and strategic partnerships. The company's focus on tokenizing real-world assets, such as its gold-backed GLDY token, aligns with regulatory advancements to enhance market transparency and efficiency. Despite recent financial losses of US$15.58 million in Q3 2025 and shareholder dilution, Streamex's revenue is projected to grow rapidly at over 100% annually, outpacing the US market average.</p>
<div class="lb-trans"><p>Streamex 擁有顯著的內部持股，通過創新舉措如開放項目和戰略合作伙伴關係，正處於增長的有利位置。該公司專注於代幣化現實世界資產，例如其黃金支持的 GLDY 代幣，與監管進展相一致，以增強市場透明度和效率。儘管在 2025 年第三季度遭遇了 1558 萬美元的財務損失和股東稀釋，Streamex 的收入預計將以每年超過 100% 的速度快速增長，超過美國市場的平均水平。</p>
</div><ul>
<li>Click here and access our complete growth analysis report to understand the dynamics of Streamex.</li>
<li>According our valuation report, there's an indication that Streamex's share price might be on the expensive side.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們的完整增長分析報告，以瞭解 Streamex 的動態。</li>
<li>根據我們的估值報告，Streamex 的股價可能偏高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth"/></p>
<p>STEX Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 STEX 收益和收入增長</p>
</div><h2>Fiverr International (FVRR)</h2>
<div class="lb-trans"><h2>Fiverr International (FVRR)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Fiverr International Ltd. operates a global online marketplace and has a market cap of approximately $727.95 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Fiverr International Ltd.運營一個全球在線市場，市值約為 7.2795 億美元。</p>
</div><p><strong>Operations:</strong> The company generates $427.40 million in revenue from its Internet Software &amp; Services segment.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司從其互聯網軟件和服務部門產生 4.2740 億美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 11.6%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 11.6%</p>
</div><p>Fiverr International, with substantial insider ownership, has demonstrated strong earnings growth, reporting a net income of US$5.54 million in Q3 2025 compared to US$1.35 million the previous year. Despite revenue growth forecasts lagging behind the broader market at 6.3% annually, its earnings are projected to grow significantly at 47.5% per year, surpassing market averages. Currently trading below fair value estimates and analyst price targets suggest potential for stock appreciation amidst robust profit expansion expectations.</p>
<div class="lb-trans"><p>Fiverr International 擁有大量內部持股，展現出強勁的收益增長，在 2025 年第三季度報告的淨收入為 554 萬美元，而去年為 135 萬美元。儘管收入增長預測落後於更廣泛的市場，年增長率為 6.3%，但其收益預計將以每年 47.5% 的速度顯著增長，超過市場平均水平。目前交易價格低於公允價值估計，分析師的目標價格暗示在強勁利潤擴張預期下，股票有升值潛力。</p>
</div><ul>
<li>Click here to discover the nuances of Fiverr International with our detailed analytical future growth report.</li>
<li>According our valuation report, there's an indication that Fiverr International's share price might be on the cheaper side.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏通過我們的詳細分析未來增長報告發現 Fiverr International 的細微差別。</li>
<li>根據我們的估值報告，Fiverr International 的股價可能偏低。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown"/></p>
<p>FVRR Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 FVRR 持股分佈</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下來該怎麼辦？</h2>
</div><ul>
<li>Unlock more gems! Our Fast Growing US Companies With High Insider Ownership screener has unearthed 208 more companies for you to explore.Click here to unveil our expertly curated list of 211 Fast Growing US Companies With High Insider Ownership.</li>
<li>Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖更多寶藏！我們的高內部持股快速成長的美國公司篩選器為您挖掘了 208 家公司供您探索。點擊這裏揭示我們精心策劃的 211 家高內部持股快速成長的美國公司列表。</li>
<li>準備好不同的投資方式了嗎？通過提供可靠收入流的穩健分紅股來多樣化您的投資組合，以應對潛在的市場動盪。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>國防和災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達服務，適用於任何地方。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 贊助</p>
</div>

3 Insider-Owned Growth Stocks For Your Watchlist

- 2025 年美股表現強勁，主要指數均有顯著增長。  
- 高內部持股的成長公司吸引關注，反映內部聯繫與股東利益一致。  
- 列舉多家公司，含 Abeona Therapeutics 及 Streamex，其收入預計將顯著增長。

3 只由內部人士持有的成長型股票值得您關注